Bing Wang is the founder of Amador Bioscience. Amador Bioscience has raised $100M in total funding. Latest round: Series B.
Dr. Bing Wang is the Chairman and CEO of Amador Bioscience, a global contract research organization (CRO) specializing in translational science and clinical pharmacology. The company provides services such as bioanalysis, clinical pharmacology, regulatory affairs, and clinical research. Amador Bioscience recently secured over $60 million in Series B+ financing, following closely on its Series B round. The company is actively expanding its global presence, establishing branches in Shanghai, new laboratory facilities in California and Maryland, and a European subsidiary in Belgium. Amador Bioscience also acquired Ann Arbor Pharmacometrics Group (A2PG) to enhance its clinical pharmacology services.
Full founder directory · Investor directory · Company funding database · Fundraising library